Top segments and regional performance

Last year, the company generated ‪64.09 B‬ INR, the most of which — ‪64.09 B‬ INR — came from its top-performing segment, Pharmaceuticals, compared to ‪58.49 B‬ INR the previous year. The greatest contribution came from India, which accounted for ‪62.70 B‬ INR last year, with ‪57.02 B‬ INR the year before.